Skip to main content
MedPathMedPath Home
Clinical Trials/NL-OMON56279
NL-OMON56279
Not yet recruiting
Not Applicable

Machine Learning and Artificial Intelligence for Early Detection of Stroke and Atrial Fibrillation - MAESTRIA-AFNET 10

Kompetenznetz Vorhofflimmern e.V./Atrial Fibrillation NETwork (AFNET)0 sites150 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
Kompetenznetz Vorhofflimmern e.V./Atrial Fibrillation NETwork (AFNET)
Enrollment
150
Status
Not yet recruiting
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational non invasive

Investigators

Sponsor
Kompetenznetz Vorhofflimmern e.V./Atrial Fibrillation NETwork (AFNET)

Eligibility Criteria

Inclusion Criteria

  • •1\. Patients with paroxysmal AF (clinically defined as AF episodes less than one
  • •patients with persistent AF (clinically defined as AF episodes longer than one
  • •or patients with permanent AF (no documented sinus rhythm or possibility to
  • •restore sinus rhythm by any means).
  • •2\. Patient (or legally acceptable representative if applicable) provides
  • •written Informed Consent to participate in the study. The patient has the
  • •option to give separate consent to donate extra volume of blood during routine
  • •blood collection, that can be used for biomedical research.
  • •3\. Patient is at least 18 years of age.
  • •4\. Patient must own a Smartphone with Apple iOS Version 14\.5 (or higher) or

Exclusion Criteria

  • •1\. Any disease that limits life expectancy to less than 1 year.
  • •2\. All persons unable to provide informed consent.
  • •3\. All persons exempt from participation in a study or trial by law.
  • •4\. Any medical or psychiatric condition which, in the Investigator\*s opinion,
  • •would preclude the participant from adhering to the protocol or completing the
  • •study per protocol.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Not Applicable
se of AI in Cardiovascular Risk Prediction.Health Condition 1: E116- Type 2 diabetes mellitus with other specified complications
CTRI/2023/07/054781A
Active, not recruiting
Not Applicable
Pathology AI Platform
KCT0003460Seoul National University Hospital6,200
Completed
Not Applicable
Machine learning and artificial intelligence algorithms to assist clinical decision making.Health Condition 1: null- who are on Ventilation
CTRI/2013/03/003466Max Super speciality Hospital200
Completed
Not Applicable
Development of machine learning/artificial intelligence algorithm that can select normal people and patients with mild cognitive impairment from fNIRS signals measured during olfactory stimulation in the prefrontal cortex
KCT0007589Gwangju Institute of Science and Technology130
Not yet recruiting
Not Applicable
Advantage of Artificial Intelligence to detect COVID 19 using Chest X-Ray.Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
CTRI/2020/08/027008Institute of Technology and Institute of Pharmacy NIRMA University